|
CIAO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.337400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.983800E-01 |
| Normal-vs-Stage2 |
9.696800E-01 |
| Normal-vs-Stage3 |
5.496800E-01 |
| Normal-vs-Stage4 |
7.188400E-01 |
| Stage1-vs-Stage2 |
8.128000E-01 |
| Stage1-vs-Stage3 |
2.785600E-01 |
| Stage1-vs-Stage4 |
4.334000E-01 |
| Stage2-vs-Stage3 |
6.129800E-01 |
| Stage2-vs-Stage4 |
7.519800E-01 |
| Stage3-vs-Stage4 |
8.307600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.898400E-01 |
| Normal-vs-AfricanAmerican |
3.224000E-01 |
| Normal-vs-Asian |
5.915000E-01 |
| Caucasian-vs-AfricanAmerican |
2.730200E-01 |
| Caucasian-vs-Asian |
4.919000E-01 |
| AfricanAmerican-vs-Asian |
5.133000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.387400E-01 |
| Normal-vs-Female |
7.562000E-01 |
| Male-vs-Female |
3.572200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.789200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.194800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.695600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.522600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.333600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.583400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.460600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.743400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.714800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.323600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.491610E-01 |
| Classical-VS-Follicular |
3.189000E-04 |
| Classical-VS-Other |
2.960400E-01 |
| Classical-VS-Normal |
1.800040E-01 |
| Tall-VS-Follicular |
4.323800E-01 |
| Tall-VS-Other |
7.879200E-01 |
| Tall-VS-Normal |
6.062200E-01 |
| Follicular-VS-Other |
8.681400E-01 |
| Follicular-VS-Normal |
8.632000E-02 |
| Other-VS-Normal |
5.097200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.909400E-01 |
| Normal-vs-N1 |
5.470400E-01 |
| N0-vs-N1 |
8.529400E-01 |
|
|
